Search bioRxiv⌕ Search

Biology subjects

Jain, H.

Publications and source records attributed to Jain, H..

6 recordsLinked to original sources

IL-17A potentiates malignant T-cell viability via electron transport chain complex I in cutaneous T-cell lymphoma

Cutaneous T-cell lymphoma (CTCL) is a rare malignancy of skin-resident T cells characterized by an aberrant cytokine profile, notably elevated Interleukin-17A (IL-17A) levels. However, the functional importance of IL-17A dysregulation in the CTCL pathogenesis remains poorly understood. Our analysis revealed increased IL-17A receptor (IL-17RA) expression in CTCL patient samples, supporting the importance of IL-17A signaling in CTCL progression. Proteomic and metabolomic profiling of IL-17A-treated malignant T cells revealed mitochondrial electron transport chain (ETC) complex I as a key downstream target of IL-17A signaling. Furthermore, we confirmed the elevated expression of ETC complex I in CTCL patient samples compared to healthy control T cells, hence highlighting the clinical relevance of the IL-17A signaling-ETC complex 1 axis. Altogether, our data unveil the function of IL-17A signaling in the metabolic axis in CTCL progression, which could be useful for developing advanced therapeutic strategies. Significance statement: We uncover an IL-17A-induced electron transport chain (ETC) complex I pro-tumorigenic circuit and provide proof of concept evidence that ETC complex I can be targeted to combat the challenges posed by Cutaneous T-cell Lymphoma aggressiveness.

cancer biology↗

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection

The novel coronavirus disease (COVID-19) and any future coronavirus outbreaks will require more affordable, effective and safe treatment options to complement current ones such as Paxlovid. Drug repurposing can be a promising approach if we are able to find a rapid, robust and reliable way to down-select and screen candidates using in silico and in vitro approaches. With repurposed drugs, ex vivo models could offer a rigorous route to human clinical trials with less time invested into nonclinical animal (in vivo) studies. We have previously shown the value of commercially available ex vivo/3D airway and alveolar tissue models, and this paper takes this further by developing and validating human nasal epithelial model and embryonic stem cells derived cardiomyocyte model. Five shortlisted candidates (fluvoxamine, everolimus, pyrimethamine, aprepitant and sirolimus) were successfully compared with three control drugs (remdesivir, molnupiravir, nirmatrelvir) when tested against key variants of the SARS-CoV-2 virus including Delta and Omicron, and we were able to reconfirm our earlier finding that fluvoxamine can induce antiviral efficacy in combination with other drugs. Scalability of this high-throughput screening approach has been demonstrated using a liquid handling robotic platform for future Disease-X outbreaks.

microbiology↗

Standing Variations Modeling Captures Inter-Individual Heterogeneity in a Deterministic Model of Prostate Cancer Response to Combination Therapy

Sipuleucel-T (Provenge) is the first live cell vaccine approved for advanced, hormonally refractive prostate cancer. However, survival benefit is modest and the optimal combination or schedule of sipuleucel-T with androgen depletion remains unknown. We employ a nonlinear dynamical systems approach to modeling the response of hormonally refractive prostate cancer to sipuleucel-T. Our mechanistic model incorporates the immune response to the cancer elicited by vaccination, and the effect of androgen depletion therapy. Because only a fraction of patients benefit from sipuleucel-T treatment, inter-individual heterogeneity is clearly crucial. Therefore, we introduce our novel approach, Standing Variations Modeling, which exploits inestimability of model parameters to capture heterogeneity in a deterministic model. We use data from mouse xenograft experiments to infer distributions on parameters critical to tumor growth and to the resultant immune response. Sampling model parameters from these distributions allows us to represent heterogeneity, both at the level of the tumor cells and the individual (mouse) being treated. Our model simulations explain the limited success of sipuleucel-T observed in practice, and predict an optimal combination regime that maximizes predicted efficacy. This approach will generalize to a range of emerging cancer immunotherapies.

systems biology↗

Decoding task-specific cognitive states with slow, directed functional networks in the human brain

Flexible functional interactions among brain regions mediate critical cognitive functions. Such interactions can be measured from functional magnetic resonance imaging (fMRI) data with either instantaneous (zero-lag) or lag-based (time-lagged) functional connectivity; only the latter approach permits inferring directed functional interactions. Yet, the fMRI hemodynamic response is slow, and sampled at a timescale (seconds) several orders of magnitude slower than the underlying neural dynamics (milliseconds). It is, therefore, widely held that lag-based fMRI functional connectivity, measured with approaches like as Granger-Geweke causality (GC), provides spurious and unreliable estimates of underlying neural interactions. Experimental verification of this claim has proven challenging because neural ground truth connectivity is often unavailable concurrently with fMRI recordings. We address this challenge by combining machine learning with GC functional connectivity estimation. We estimated instantaneous and lag-based GC functional connectivity networks using fMRI data from 1000 participants, drawn from the Human Connectome Project database. A linear classifier, trained on either instantaneous or lag-based GC, reliably discriminated among seven different task and resting brain states, with over 80% cross-validation accuracy. With network simulations, we demonstrate that instantaneous and lag-based GC exploited interactions at fast and slow timescales, respectively, to achieve robust classification. With human fMRI data, instantaneous and lag-based GC identified distinct, cognitive core networks. Finally, variations in GC connectivity explained inter-individual variations in a variety of cognitive scores. Our findings show that instantaneous and lag-based methods reveal complementary aspects of functional connectivity in the brain, and suggest that slow, directed functional interactions, estimated with fMRI, provide robust markers of behaviorally relevant cognitive states.\n\nAuthor SummaryFunctional MRI (fMRI) is a leading, non-invasive technique for mapping networks in the human brain. Yet, fMRI signals are noisy and sluggish, and fMRI scans are acquired at a timescale of seconds, considerably slower than the timescale of neural spiking (milliseconds). Can fMRI, then, be used to infer dynamic processes in the brain such as the direction of information flow among brain networks? We sought to answer this question by applying machine learning to fMRI scans acquired from 1000 participants in the Human Connectome Project (HCP) database. We show that directed brain networks, estimated with a technique known as Granger-Geweke Causality (GC), accurately predicts individual subjects task-specific cognitive states inside the scanner, and also explains variations in a variety of behavioral scores across individuals. We propose that directed functional connectivity, as estimated with fMRI-GC, is relevant for understanding human cognitive function.

neuroscience↗

Neurally-constrained modeling of human gaze strategies in a change blindness task

Visual attention enables us to engage selectively with the most important events in the world around us. Yet, sometimes, we fail to notice salient events. \"Change blindness\" - the surprising inability to detect and identify salient changes that occur in flashing visual images - enables measuring such failures in a laboratory setting. We discovered that human participants (n=39) varied widely (by two-fold) in their ability to detect changes when tested on a laboratory change blindness task. To understand the reasons for these differences in change detection abilities, we characterized eye-movement patterns and gaze strategies as participants scanned these images. Surprisingly, we found no systematic differences between scan paths, fixation maps or saccade patterns between participants who were successful at detecting changes, versus those who were not. Yet, two low-level gaze metrics - the mean fixation duration and the variance of saccade amplitudes - systematically predicted change detection success. To explain the mechanism by which these gaze metrics could influence performance, we developed a neurally constrained model, based on the Bayesian framework of sequential probability ratio testing (SPRT), which simulated gaze strategies of successful and unsuccessful observers. The models ability to detect changes varied systematically with mean fixation duration and saccade amplitude variance, closely mimicking observations in the human data. Moreover, the models success rates correlated robustly with human observers success rates, across images. Our model explains putative human attention mechanisms during change blindness tasks and provides key insights into effective strategies for shifting gaze and attention for artificial agents navigating dynamic, crowded environments.\n\nAuthor SummaryOur brain has the remarkable capacity to pay attention, selectively, to the most important events in the world around us. Yet, sometimes, we fail spectacularly to notice even the most salient events. We tested this phenomenon in the laboratory with a change-blindness experiment, by having participants freely scan and detect changes across discontinuous image pairs. Participants varied widely in their ability to detect these changes. Surprisingly, their success correlated with differences in low-level gaze metrics. A Bayesian model of eye movements, which incorporated neural constraints on stimulus encoding, could explain the reason for these differences, and closely mimicked human performance in this change blindness task. The models gaze strategies provide relevant insights for artificial, neuromorphic agents navigating dynamic, crowded environments.

neuroscience↗

The role of structural pleiotropy and regulatory evolution in the retention of heteromers of paralogs

Many paralogs derive from the duplication of genes encoding homomeric proteins. Such duplication events lead to the formation of homomers and heteromers, thus creating new structures from a single event. We exhaustively characterize this phenomenon using the budding yeast protein-protein interaction network. We observe that paralogs that heteromerize are very frequent and less functionally diverged than those that lost this property, raising the possibility that heteromerization prevents functional divergence. Using in silico evolution, we show that for homomers and heteromers that share binding interfaces, mutations on one complex have pleiotropic effects on the other complex, resulting in highly correlated responses to selection. As a result, heteromerization could be preserved indirectly due to selection for the maintenance of homomers. By integrating data on gene expression and protein localization, we find that regulatory evolution could play a role in overcoming these structural pleiotropic effects and in allowing paralog functional divergence.

evolutionary biology↗